Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 25, 2025 07:55 ET | Source: ZyVersa Therapeutics

ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million in Partnership with Williamsburg Venture Holdings to Fund Clinical Development of Cholesterol Efflux Mediator™ VAR 200

WESTON, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for...
January 13, 2022 19:00 ET | Source: Allied Market Research

Nephrology Drugs Market Predicts to Generate $23.40 Billion by 2030, Says Allied Market Research

Portland, OR, Jan. 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global nephrology drugs market generated $14.50 billion in 2020, and is projected to...